Jefferies reiterates Buy rating on Clorox stock, maintains $155 price target

Published 10/09/2025, 11:26
Jefferies reiterates Buy rating on Clorox stock, maintains $155 price target

Investing.com - Jefferies maintained its Buy rating and $155.00 price target on Clorox (NYSE:CLX) following discussions with the company’s management team. According to InvestingPro data, the stock currently trades at $125.68, with analysts’ targets ranging from $115 to $166.

The research firm noted that Clorox’s Enterprise Resource Planning (ERP) system rollout experienced expected challenges, but the company has now moved past these implementation issues.

Jefferies indicated that shipment shortfalls from the first quarter are expected to shift into the second quarter, which should allow Clorox to maintain its full-year targets intact despite the temporary disruption.

The firm emphasized that gaining clarity on Clorox’s normalized performance by 2027 remains a key factor in the investment thesis, with Jefferies expressing increased confidence in its earnings projection of $7.40 per share, which exceeds the Street consensus of $7.00.

Jefferies suggested that current market volatility presents an opportunity for investors in Clorox stock, concluding that the Buy rating remains appropriate.

In other recent news, The Clorox Company reported impressive financial results for the fourth quarter and full year of 2025. The company’s earnings per share (EPS) reached $2.87, significantly surpassing the analyst forecast of $2.21, representing a 29.86% surprise. Revenue also exceeded expectations, totaling $2 billion against the anticipated $1.94 billion. In addition to its financial performance, Clorox introduced a new product called Clorox Screen+ Sanitizing Wipes. These wipes are designed to clean and sanitize touchscreens and other electronic devices, addressing concerns about germs on shared devices in various settings. The product claims to kill 99.9% of bacteria while effectively removing fingerprints, dust, and smudges without causing damage to sensitive screens. These developments reflect Clorox’s ongoing efforts to innovate and meet consumer needs.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.